Literature DB >> 30765393

Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.

Natsumi Namba1,2, Aya Kawasaki3, Ken-Ei Sada4, Fumio Hirano5,6, Shigeto Kobayashi7, Hidehiro Yamada8, Hiroshi Furukawa1,9, Kota Shimada9,10, Atsushi Hashimoto9, Toshihiro Matsui9, Kenji Nagasaka11, Takahiko Sugihara12, Aika Suzuki13, Kunihiro Yamagata14, Takayuki Sumida15, Shigeto Tohma9,16, Sakae Homma13, Shoichi Ozaki8, Hiroshi Hashimoto17, Hirofumi Makino18, Yoshihiro Arimura19, Masayoshi Harigai20, Naoyuki Tsuchiya3.   

Abstract

Entities:  

Keywords:  ANCA-associated vasculitis; MUC5B; interstitial lung disease; myeloperoxidase-ANCA; polymorphism

Mesh：

Substances：

Year:  2019        PMID： 30765393     DOI： 10.1136/annrheumdis-2018-214263

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.

Authors:  Shuqiao Yang; Dandan Chai; Yihua Li; Yuanying Wang; Xi Zhan; Liming Zhang; Jing Wang; Qiao Ye
Journal:  Clin Rheumatol       Date:  2021-11-27       Impact factor: 2.980

Review 2.  Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.

Authors:  Giorgio Trivioli; Ana Marquez; Davide Martorana; Michelangelo Tesi; Andreas Kronbichler; Paul A Lyons; Augusto Vaglio
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

3.  Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study.

Authors:  Aya Kawasaki; Natsumi Namba; Ken-Ei Sada; Fumio Hirano; Shigeto Kobayashi; Kenji Nagasaka; Takahiko Sugihara; Nobuyuki Ono; Takashi Fujimoto; Makio Kusaoi; Naoto Tamura; Kunihiro Yamagata; Takayuki Sumida; Hiroshi Hashimoto; Shoichi Ozaki; Hirofumi Makino; Yoshihiro Arimura; Masayoshi Harigai; Naoyuki Tsuchiya
Journal:  Arthritis Res Ther       Date:  2020-10-16       Impact factor: 5.156

4.  Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.

Authors:  Eiko Iwasa; Yu Fujiyoshi; Yuki Kubota; Ryota Kimura; Rebecca E Chandler; Henric Taavola; G Niklas Norén; Rika Wakao
Journal:  Drug Saf       Date:  2020-11       Impact factor: 5.606

5.  Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing.

Authors:  Johanna K Sandling; Pascal Pucholt; Lina Hultin Rosenberg; Fabiana H G Farias; Sergey V Kozyrev; Maija-Leena Eloranta; Andrei Alexsson; Matteo Bianchi; Leonid Padyukov; Christine Bengtsson; Roland Jonsson; Roald Omdal; Benedicte A Lie; Laura Massarenti; Rudi Steffensen; Marianne A Jakobsen; Søren T Lillevang; Karoline Lerang; Øyvind Molberg; Anne Voss; Anne Troldborg; Søren Jacobsen; Ann-Christine Syvänen; Andreas Jönsen; Iva Gunnarsson; Elisabet Svenungsson; Solbritt Rantapää-Dahlqvist; Anders A Bengtsson; Christopher Sjöwall; Dag Leonard; Kerstin Lindblad-Toh; Lars Rönnblom
Journal:  Ann Rheum Dis       Date:  2020-10-09       Impact factor: 19.103

Review 6.  Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Gian Luca Erre; Carlo Salvarani; Andreina Manfredi
Journal:  Drugs Context       Date:  2021-01-15

Review 7.  Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.

Authors:  Hideaki Yamakawa; Yuko Toyoda; Tomohisa Baba; Tomoo Kishaba; Taiki Fukuda; Tamiko Takemura; Kazuyoshi Kuwano
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

8.  The Sound of Interconnectivity; The European Vasculitis Society 2022 Report.

Authors:  Allyson C Egan; Andreas Kronbichler; Irmgard Neumann; Alessandra Bettiol; Nicholas Carlson; Maria C Cid; Giacomo Emmi; Seerapani Gopaluni; Lorraine Harper; Thomas Hauser; Mark A Little; Raashid A Luqmani; Alfred Mahr; Mark McClure; Aladdin J Mohammad; Karl Emil Nelveg-Kristensen; Sophie Ohlsson; Chen Au Peh; Matthew Rutherford; Beatriz Sanchez Alamo; Jennifer Scott; Mårten Segelmark; Rona M Smith; Wladimir M Szpirt; Gunnar Tomasson; Giorgio Trivioli; Augusto Vaglio; Michael Walsh; Maria Wester Trejo; Kerstin Westman; Ingeborg M Bajema; David R W Jayne
Journal:  Kidney Int Rep       Date:  2022-05-25

Review 9.  Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.

Authors:  Aya Kawasaki; Naoyuki Tsuchiya
Journal:  Genes Immun       Date:  2021-03-08       Impact factor: 2.676

Review 10.  MPO-ANCA positive interstitial pneumonia: Current knowledge and future perspectives.

Authors:  Masashi Bando; Sakae Homma; Masayoshi Harigai
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.